Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem Combinations for Early Bactericidal Activity in Pulmonary TB
NCT04629378Phase 2Completed
- Sponsor
- TASK Foundation
- Start
- Aug 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of meropenem in pulmonary tuberculosis (TB), sponsored by TASK Foundation. Started Aug 2020; status: completed.
02
Drugs
meropenem
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT04629378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04629378.